What is the appropriate management of epistaxis in a pregnant woman?

Management of Epistaxis in Pregnancy

Manage epistaxis in pregnant women using the same evidence-based approach as non-pregnant patients, starting with conservative measures (pressure, topical vasoconstrictors, cautery) and escalating to packing or surgical intervention only if conservative treatment fails. 1

Initial Conservative Management

The first-line approach follows standard epistaxis protocols regardless of pregnancy status:

• Have the patient lean forward and pinch the soft part of the nose for at least 5 minutes, extending to 15 minutes if bleeding slows. 1
• Apply topical vasoconstrictors (oxymetazoline or phenylephrine spray) after blowing the nose to clear clots—spray 2 times in the bleeding nostril and continue holding pressure for 5 minutes, repeatable once. 1
• Identify the bleeding site through examination, as anterior epistaxis occurs in 95% of cases. 1, 2
• Perform cauterization with silver nitrate or electrocautery if a specific bleeding point is identified, which is appropriate for most anterior bleeds. 1

Pregnancy-Specific Considerations

While the management approach remains standard, recognize these pregnancy-related factors:

• Epistaxis prevalence increases significantly in pregnancy (20.3% vs 6.2% in non-pregnant women) due to increased nasal mucosal vascularity and hormonal changes. 3, 4
• Women with epistaxis during pregnancy have increased risk of postpartum hemorrhage (10.7% vs 6.7%), making documentation and follow-up important. 4
• Exclude pregnancy-specific pathology such as pyogenic granuloma (lobular capillary hemangioma), which can cause severe bleeding and requires ENT evaluation with nasal endoscopy. 3

When Conservative Measures Fail

If initial treatment is unsuccessful:

• Apply anterior nasal packing directly over the bleeding point (used in 73.86% of epistaxis cases). 1, 2
• Consider posterior packing only for confirmed posterior bleeds (5% of cases), with strict adherence to follow-up for removal within the timeframe specified by the treating clinician. 1, 2
• Use topical tranexamic acid on packing as an adjunct (applied in 17% of cases). 2
• Prescribe prophylactic antibiotics if infection risk is high with non-resorbable packing to prevent toxic shock syndrome and sinusitis. 1

Escalation to Advanced Interventions

For severe, refractory epistaxis:

• Request ENT consultation early rather than delaying, particularly if bleeding is difficult to control or if there is concern for underlying pathology. 1, 5
• Consider nasal endoscopy to identify posterior bleeding sites (which can be localized in 87-93% of cases) and exclude masses or foreign bodies. 1
• Surgical intervention (sphenopalatine artery ligation) or embolization may be necessary in rare severe cases, though delivery of the fetus often resolves the bleeding in pregnancy-related epistaxis. 6, 5, 7

Critical Pitfalls to Avoid

• Do not delay multidisciplinary involvement (obstetrics, ENT, anesthesia) when epistaxis is severe, as life-threatening hemorrhage can occur. 6, 5
• Do not leave non-resorbable packing in place beyond recommended duration, as this increases risk of septal perforation, infection, and pressure necrosis. 1
• Do not assume all pregnancy epistaxis is benign—always evaluate for pyogenic granuloma in cases of severe or recurrent bleeding, as these lesions may require surgical excision. 3
• Avoid aspirin and NSAIDs for pain control; use acetaminophen instead to prevent further bleeding. 1

Post-Treatment Instructions

After successful hemostasis:

• Educate patients on preventive measures: nasal saline gel/spray 1-3 times daily, humidification, avoiding nose picking and vigorous blowing. 1
• Restrict strenuous activity, heavy lifting over 10 pounds, and bending over for at least one week after cautery or packing. 1
• Document outcomes within 30 days or ensure appropriate transition of care, particularly for patients requiring packing, surgery, or advanced interventions. 1
• Instruct patients to seek immediate care if bleeding recurs despite pressure and vasoconstrictor spray, or if they develop fever >101°F, vision changes, facial swelling, or signs of infection. 1